申请人:MITSUBISHI CHEMICAL CORPORATION
公开号:EP0652217A1
公开(公告)日:1995-05-10
The N-substituted imidazole derivatives of the following formula (1)
wherein A is
X is -O-, -NHCO- or -NH-, 1 is an integer of 2 to 6; m is 0 or 1; n is 1 or 2;ring α, ring β and ring γ are independently unsubstituted or substituted by one or more substituents selected from the group consisting of a halogen atom, C₁ ~ C₃ alkyl, C₁ ~ C₃ alkoxy and cyano; or its pharmaceutically acceptable salt, or their hydrates, show excellent anti-hypertensive, anti-hyperlipemic and blood sugar lowering activity, and are useful as excellent antihypertensives, preventives or remedies for ischemic cardiac diseases such as angina, myocardial infarction, heart failure, arteriosclerosis, or as preventives or remedies for diabetes and complications thereof.
以下是上述公式(1)中的N-取代咪唑衍生物的中文翻译:
其中A为
X为-O-,-NHCO-或-NH-,1为2到6的整数;m为0或1;n为1或2;环α,环β和环γ独立地未取代或被来自卤素原子、C₁〜C₃烷基、C₁〜C₃烷氧基和氰基的一个或多个取代基取代;或其药学上可接受的盐,或其水合物,表现出优异的抗高血压、抗高脂血症和降血糖活性,并且可用作优秀的降压药、缓解或治疗缺血性心脏疾病(如心绞痛、心肌梗死、心力衰竭、动脉硬化)的药物,或作为糖尿病及其并发症的预防或治疗药物。